Skip to Main Content »

Welcome to the LifeTech Research Report Store

Category Navigation:

You're currently on:

Medivation's MDV3100 - Promising early data in advanced prostate cancer

Availability: In stock.


Product Description

MDV31000 is a novel anti-androgen in development for advanced prostate cancer. This report reviews the mechanism, the early data, the safety profile (with a focus on seizures), the prospects, competition and the market opportunity.

Published: July 10th, 2009

Number of pages: 25

Authors: Dr. Senai Asefaw, Dr. Ilana Fogelman and Dr. Ellen Brady

* Required Fields

Add Items to Cart